ScholarGate
Assistente

Pyelonephritis (Acute and Chronic)

Pyelonephritis is infection and inflammation of the kidney and renal pelvis, the principal form of upper urinary tract infection. Acute pyelonephritis is a systemic illness that typically presents with fever and flank pain, whereas chronic pyelonephritis refers to longstanding inflammation and scarring of the kidney, often linked to recurrent infection and underlying structural or functional abnormalities.

Trova un argomento con PaperMindIn arrivoFind papers & topics
Tools & resources
Scarica le diapositive
Learn & explore
VideoIn arrivo

Definition

Acute pyelonephritis is acute bacterial infection of the renal parenchyma and pelvis, usually presenting with fever, flank pain, and bacteriuria; chronic pyelonephritis denotes chronic tubulointerstitial inflammation and renal scarring associated with recurrent or persistent infection, often in the setting of reflux or obstruction.

Scope

This topic covers the definition and distinction of acute and chronic pyelonephritis, their microbiology and pathogenesis, typical clinical features, and the evidence and guidelines that describe their management. It is a reference and educational entry and does not provide dosing or individualized treatment guidance.

Core questions

  • How is upper urinary tract infection distinguished from lower-tract cystitis?
  • What features mark pyelonephritis as uncomplicated versus complicated?
  • What is the relationship between recurrent infection, reflux, obstruction, and chronic renal scarring?
  • How do the duration and route of described therapy relate to severity and host factors?

Key concepts

  • Acute versus chronic pyelonephritis
  • Flank pain and systemic features
  • Ascending infection and vesicoureteral reflux
  • Complicated versus uncomplicated upper-tract infection
  • Renal scarring
  • Blood and urine cultures in assessment

Mechanisms

Most pyelonephritis arises by ascent of uropathogens from the bladder up the ureters to the renal pelvis and parenchyma, where infection provokes an acute inflammatory response with systemic features such as fever. Factors that impair urine flow or promote reflux, including obstruction and vesicoureteral reflux, are associated in the literature with increased risk and severity. Repeated or persistent infection, particularly in the presence of these abnormalities, is linked to the tubulointerstitial inflammation and scarring that characterize chronic pyelonephritis. Hematogenous seeding of the kidney is a less common alternative route described for certain organisms.

Clinical relevance

Pyelonephritis is a more serious manifestation of urinary infection than cystitis, carrying greater systemic risk, and its study informs how upper-tract infection is recognized and investigated. Trials such as Sandberg and colleagues' comparison of treatment durations illustrate how the evidence base for therapy length has been built. This entry describes these concepts for reference and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Acute pyelonephritis is less common than cystitis but accounts for substantial morbidity and is a frequent reason for hospitalization for urinary infection, with a female predominance in young adults that parallels the epidemiology of lower-tract infection. Foxman's epidemiologic work situates pyelonephritis within the broader burden of urinary tract infection. Escherichia coli is the predominant causative organism in most series.

History

Pyelonephritis was clarified as a distinct upper-tract entity as quantitative urine culture and imaging allowed infection of the renal parenchyma to be characterized in the twentieth century. The recognition of vesicoureteral reflux and obstruction as contributors to recurrent infection and renal scarring shaped the concept of chronic pyelonephritis. More recently, randomized trials of treatment duration and the inclusion of pyelonephritis in international UTI guidelines have refined how the condition is described and managed.

Debates

How long should treatment for acute pyelonephritis continue?
Randomized evidence, including Sandberg and colleagues' non-inferiority trial of shorter versus longer ciprofloxacin courses in women, has informed a trend toward shorter durations for selected uncomplicated cases, while severity, host factors, and resistance complicate any single answer.

Key figures

  • Kalpana Gupta
  • Thomas M. Hooton
  • Torsten Sandberg
  • Betsy Foxman

Related topics

Seminal works

  • gupta-2011
  • sandberg-2012
  • foxman-2002

Frequently asked questions

How does pyelonephritis differ from cystitis?
Cystitis is infection confined to the bladder and presents mainly with lower urinary tract symptoms such as dysuria and frequency, whereas pyelonephritis involves the kidney and renal pelvis and typically produces systemic features such as fever and flank pain, marking it as upper urinary tract infection.
What is chronic pyelonephritis?
Chronic pyelonephritis refers to longstanding inflammation and scarring of the kidney associated with recurrent or persistent infection, frequently in the setting of vesicoureteral reflux or obstruction, rather than to a single acute episode.

Methods for this concept

Related concepts